Ecovyst Inc.(ECVT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,095 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ECVT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Ecovyst Inc. (ECVT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ECVT at 36.6/100 on a 32-signal composite quality model, placing it at rank #2,095 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (17.4) and profitability (19.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 49.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Ecovyst Inc. reports quarterly revenue of $215.0M, net income of $4.3M, an operating margin of 5.8%. Top institutional holders of ECVT by reported 13-F value include Rubric Capital Management, BlackRock,, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. ECVT trades on the NYSE exchange and files with the SEC under CIK 1708035. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ECVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ecovyst Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$215.0M
Net Income
Q1 2026
$4.3M
Free Cash Flow
Q1 2026
$2.8M
Operating Margin
Q1 2026
5.8%
D/E Ratio
Q1 2026
0.68
Get alerted when ECVT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Ecovyst Inc. including:
Top Institutional Holders of ECVT
Rubric Capital Management LP
$117.5M9,136,067 shBlackRock, Inc.
$112.3M8,734,220 shDIMENSIONAL FUND ADVISORS LP
$83.6M6,498,654 shHOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
$69.6M5,413,862 shVANGUARD PORTFOLIO MANAGEMENT LLC
$67.4M5,244,406 shVANGUARD CAPITAL MANAGEMENT LLC
$64.0M4,977,580 shBROWN ADVISORY INC
$62.3M4,842,174 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$62.1M4,829,034 shFMR LLC
$57.5M4,467,425 shAllspring Global Investments Holdings, LLC
$49.8M3,798,389 sh
| Fund | Value | Shares |
|---|---|---|
| Rubric Capital Management LP | $117.5M | 9,136,067 |
| BlackRock, Inc. | $112.3M | 8,734,220 |
| DIMENSIONAL FUND ADVISORS LP | $83.6M | 6,498,654 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $69.6M | 5,413,862 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $67.4M | 5,244,406 |
| VANGUARD CAPITAL MANAGEMENT LLC | $64.0M | 4,977,580 |
| BROWN ADVISORY INC | $62.3M | 4,842,174 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $62.1M | 4,829,034 |
| FMR LLC | $57.5M | 4,467,425 |
| Allspring Global Investments Holdings, LLC | $49.8M | 3,798,389 |
More Healthcare Companies
View all Healthcare →Put ECVT on your watchlist
Track score changes the day Ecovyst Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ECVT a good stock to buy?
13F Pro's AI-powered analysis of Ecovyst Inc. (ECVT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ECVT are available on the ECVT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ECVT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ECVT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Ecovyst Inc.'s investment landscape.